|
Kucuk, O; Kilton, L; Wade, J L et al. (2000) Phase II trial of menogaril in patients with previously treated multiple myeloma or chronic lymphocytic leukemia. Am J Clin Oncol 23:379-83
|
|
Rosen, F; Vokes, E E; Lad, T et al. (1995) Phase II study of amonafide in the treatment of patients with advanced squamous cell carcinoma of the head and the neck. An Illinois Cancer Center study. Invest New Drugs 13:249-52
|
|
Shevrin, D H; Lad, T E; Guinan, P et al. (1994) Phase II trial of echinomycin in advanced hormone-resistant prostate cancer. An Illinois Cancer Council study. Invest New Drugs 12:65-6
|
|
Kies, M S; Grinblatt, D; Runge-Morris, M et al. (1994) Phase II study of intravenous melphalan (NSC-8806) in the treatment of patients with advanced squamous carcinoma of the head and neck. Invest New Drugs 12:45-7
|
|
Kilton, L J; Ashenhurst, J B; Wade 3rd, J L et al. (1994) Phase II study of fludarabine phosphate for gastric adenocarcinoma. An Illinois Cancer Center trial. Invest New Drugs 12:163-6
|
|
Giovanazzi-Bannon, S; Rademaker, A; Lai, G et al. (1994) Treatment tolerance of elderly cancer patients entered onto phase II clinical trials: an Illinois Cancer Center study. J Clin Oncol 12:2447-52
|
|
Locker, G Y; Kilton, L; Khandekar, J D et al. (1994) High-dose aminothiadiazole in advanced colorectal cancer. An Illinois Cancer Center phase II trial. Invest New Drugs 12:299-301
|
|
Shevrin, D H; Kilton, L J; Lad, T E et al. (1994) Phase II trial of 6-thioguanine in advanced renal cell carcinoma. An Illinois Cancer Center study. Invest New Drugs 12:345-6
|
|
Cobleigh, M A; Dowlatshahi, K; Deutsch, T A et al. (1993) Phase I/II trial of tamoxifen with or without fenretinide, an analog of vitamin A, in women with metastatic breast cancer. J Clin Oncol 11:474-7
|
|
Kuzel, T M; Tallman, M S; Shevrin, D et al. (1993) A phase II study of continuous infusion 5-fluorouracil in advanced hormone refractory prostate cancer. An Illinois Cancer Center Study. Cancer 72:1965-8
|
Showing the most recent 10 out of 29 publications
